Nykaa, ACC, HDFC AMC, Indus Towers, Page Ind shares fall up to 3% on exclusion from Nifty Next 50
PNB, Trent, TVS Motor, Shriram Finance, and Zydus Lifesciences will replace these five stocks in the Nifty Next 50 index, effective from September 29, 2023.
Zydus Lifesciences gets USFDA nod for cancer drug; stock hits 52-week high
The share price of the drugmaker has risen 92% in the last one year from its 52-week low of ₹340.60 touched on July 27, 2022.
Zydus Lifesciences gets USFDA nod for osteoporosis drug; stock hits 52-week high
The USFDA has allowed Zydus to manufacture and market Estradiol Transdermal System USP in the U.S; the drug will be produced at the group’s facility in Moraiya, Ahmedabad.
What’s behind Indian pharma cos’ global acquisition spree
India's healthcare firms spent $4.32 billion during January to June of 2022 on mergers and acquisitions, compared to $2.02 billion in the same period last year
Zydus Lifesciences gets final USFDA approval for antifungal drug
The Ahmedabad-based pharma company has received seven approvals from the U.S. drug regulator so far in October.
Gap-down opening seen for Sensex, Nifty; Suzlon Energy, Bata, Zydus Lifesciences shares eyed
The Sensex and Nifty are set to open lower on Monday, following weak cues from Asian peers and a negative finish on Wall Street on Friday.